In terms of immune checkpoints, cervical cancer is known to frequently detect high levels of CTLA4 and PD1/PD-L1, which are often expressed in dendritic cells of cervical intraepithelial neoplasia (CIN) samples (77, 78). This evidence concerns the gene CD274 and cervical cancer.